Article info

Download PDFPDF

Vimentin as a target for the treatment of COVID-19

Authors

  • Zhenlin Li Biological Adaptation and Ageing, CNRS UMR 8256, Inserm U1164, Sorbonne Université, Institut de Biologie Paris-Seine, Paris, France PubMed articlesGoogle scholar articles
  • Denise Paulin Biological Adaptation and Ageing, CNRS UMR 8256, Inserm U1164, Sorbonne Université, Institut de Biologie Paris-Seine, Paris, France PubMed articlesGoogle scholar articles
  • Patrick Lacolley Inserm, UMR_S 1116, DCAC, Université de Lorraine, Nancy, Lorraine, France PubMed articlesGoogle scholar articles
  • Dario Coletti Biological Adaptation and Ageing, CNRS UMR 8256, Inserm U1164, Sorbonne Université, Institut de Biologie Paris-Seine, Paris, FranceDepartment of Anatomy, Histology, Forensic Medicine & Orthopedics, Histology & Medical Embryology Section, Sapienza University of Rome, Roma, Lazio, Italy PubMed articlesGoogle scholar articles
  • Onnik Agbulut Biological Adaptation and Ageing, CNRS UMR 8256, Inserm U1164, Sorbonne Université, Institut de Biologie Paris-Seine, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Onnik Agbulut; onnik.agbulut{at}sorbonne-universite.fr
View Full Text

Citation

Li Z, Paulin D, Lacolley P, et al
Vimentin as a target for the treatment of COVID-19

Publication history

  • Received April 27, 2020
  • Revised August 24, 2020
  • Accepted August 25, 2020
  • First published September 9, 2020.
Online issue publication 
September 09, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.